NovaBridge Biosciences (NBP) Non Operating Income (2023 - 2025)
NovaBridge Biosciences (NBP) reported Non Operating Income of -$190000.0 for Q2 2025, down 103.13% year-over-year from $6.1 million in Q2 2024, and down 177.87% quarter-over-quarter from $244000.0 in Q1 2025.
NovaBridge Biosciences (NBP) Non Operating Income (2023 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 3 years of Non Operating Income data on file, last reported at -$190000.0 in Q2 2025.
- Non Operating Income for Q2 2025 came in at -$190000.0, down 103.13% year-over-year; the trailing twelve-month figure through Jun 2025 was -$10.1 million (down 214.35% YoY), and the FY2025 annual result was -$1.7 million, up 64.35% from the prior year.
- Non Operating Income slipped to -$190000.0 in Q2 2025 per NBP's latest filing, from $244000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $6.1 million in Q2 2024 and troughed at -$16.4 million in Q2 2023.
- A 3-year average of -$2.0 million and a median of $244000.0 in 2025 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income sank 542.54% in 2024, then soared 141.57% in 2025.
- A 3-year view of Non Operating Income shows it stood at $1.0 million in 2023, then slumped by 67.39% to $330000.0 in 2024, then plunged by 157.58% to -$190000.0 in 2025.
- Business Quant data shows NBP's Non Operating Income at -$190000.0 in Q2 2025, $244000.0 in Q1 2025, and $330000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 9.35 Mn |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -190,000.00 |
| Mar 31, 2025 | 244,000.00 |
| Dec 31, 2024 | 330,000.00 |
| Sep 30, 2024 | -10.53 Mn |
| Jun 30, 2024 | 6.07 Mn |
| Mar 31, 2024 | -587,000.00 |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 2.38 Mn |
| Jun 30, 2023 | -16.41 Mn |